Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marcel Deckert

Showing results (1-10 of 57) with videos related to

Pageof 6
Sort By:
Medecine Sciences : M/S|December 13, 2006
[The adaptor protein 3BP2 in leukocyte signaling]Marcel Deckert
Medecine Sciences : M/S|July 3, 2003
[Lymphocytes: what is "Vav"]Céline Charvet, Marcel Deckert
Medecine Sciences : M/S|July 9, 2015
[SH3BP2 heterozygous mutation amplifies macrophage inflammatory responses to infection in a mouse model of cherubism]Marcel Deckert, Virginie Prod'Homme
Advances in Experimental Medicine and Biology|June 29, 2006
The adapter 3BP2: how it plugs into leukocyte signalingMarcel Deckert, Robert Rottapel
Cancers|July 27, 2022
Emerging Role of Deubiquitinating Enzymes (DUBs) in Melanoma PathogenesisMickael Ohanna, Pierric Biber, Marcel Deckert
Cancers|May 30, 2020
Bad Neighborhood: Fibrotic Stroma as a New Player in Melanoma Resistance to Targeted TherapiesSerena Diazzi, Sophie Tartare-Deckert, Marcel Deckert
Oncogenesis|February 11, 2023
The mechanical phenotypic plasticity of melanoma cell: an emerging driver of therapy cross-resistanceSerena Diazzi, Sophie Tartare-Deckert, Marcel Deckert
The Journal of Biological Chemistry|December 27, 2002
The chaperone protein 14-3-3 interacts with 3BP2/SH3BP2 and regulates its adapter functionIsabelle Foucault, Yun-Cai Liu, Alain Bernard, et al.
Medecine Sciences : M/S|November 5, 2020
[Melanoma therapeutic escape: the biomechanical track]Margaux Lecacheur, Christophe A Girard, Marcel Deckert, et al.
The Journal of Biological Chemistry|February 23, 2002
Vav1 couples T cell receptor to serum response factor-dependent transcription via a MEK-dependent pathwayCeline Charvet, Patrick Auberger, Sophie Tartare-Deckert, et al.
Pageof 6

Showing results (1-10 of 57) with videos related to

Sort By:
Pageof 6
Medecine Sciences : M/S|December 13, 2006
[The adaptor protein 3BP2 in leukocyte signaling]Marcel Deckert
Medecine Sciences : M/S|July 3, 2003
[Lymphocytes: what is "Vav"]Céline Charvet, Marcel Deckert
Medecine Sciences : M/S|July 9, 2015
[SH3BP2 heterozygous mutation amplifies macrophage inflammatory responses to infection in a mouse model of cherubism]Marcel Deckert, Virginie Prod'Homme
Advances in Experimental Medicine and Biology|June 29, 2006
The adapter 3BP2: how it plugs into leukocyte signalingMarcel Deckert, Robert Rottapel
Cancers|July 27, 2022
Emerging Role of Deubiquitinating Enzymes (DUBs) in Melanoma PathogenesisMickael Ohanna, Pierric Biber, Marcel Deckert
Cancers|May 30, 2020
Bad Neighborhood: Fibrotic Stroma as a New Player in Melanoma Resistance to Targeted TherapiesSerena Diazzi, Sophie Tartare-Deckert, Marcel Deckert
Oncogenesis|February 11, 2023
The mechanical phenotypic plasticity of melanoma cell: an emerging driver of therapy cross-resistanceSerena Diazzi, Sophie Tartare-Deckert, Marcel Deckert
The Journal of Biological Chemistry|December 27, 2002
The chaperone protein 14-3-3 interacts with 3BP2/SH3BP2 and regulates its adapter functionIsabelle Foucault, Yun-Cai Liu, Alain Bernard, et al.
Medecine Sciences : M/S|November 5, 2020
[Melanoma therapeutic escape: the biomechanical track]Margaux Lecacheur, Christophe A Girard, Marcel Deckert, et al.
The Journal of Biological Chemistry|February 23, 2002
Vav1 couples T cell receptor to serum response factor-dependent transcription via a MEK-dependent pathwayCeline Charvet, Patrick Auberger, Sophie Tartare-Deckert, et al.
Pageof 6